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Loss-of-function mutations in Whn (Hfh11, Foxn1),
a winged-helix/forkhead transcription factor, cause
the nude phenotype, which is characterized by the
abnormal morphogenesis of the epidermis, hair fol-
licles, and thymus. To delineate the biochemical
pathway of Whn, we investigated its upstream regu-
lation and downstream effects using primary kerati-
nocytes from wild-type and transgenic mice. The
transgenic animals express whn from the involucrin
promoter, which is active in keratinocytes undergo-
ing terminal differentiation. In wild-type cultures,
as in the epidermis, Whn was induced during the
early stages of terminal differentiation and declined
during later stages. In transgenic keratinocytes, whn
overexpression altered the terminal differentiation
program, stimulating an early differentiation marker
(keratin 1) and suppressing later markers (pro®lag-
grin, loricrin, and involucrin). These results suggest
a role for Whn in the stepwise or temporal regula-
tion of differentiation, as Whn can ensure that the
differentiation program is carried out in proper
sequence. Before the start of differentiation, Whn
levels were suppressed by the p42/p44 mitogen-acti-
vated protein kinase cascade, and this signaling path-
way was rapidly inactivated as differentiation began.
Thus, as keratinocytes commit to terminal differenti-
ation, mitogen-activated protein kinase signaling
decreases, which permits the induction of Whn; Whn
then activates early features of the differentiation
program. Key words: Foxn1/Hfh11/keratinocyte/mito-
gen-activated protein kinase/Whn. J Invest Dermatol
118:303±309, 2002
T
he epidermis and hair follicles are related epithelial
structures with many similarities in their development,
organization, and self-renewal (reviewed in Fuchs,
1990; Hardy, 1992). Both originate from proliferative
cell populations that exhibit relatively few differen-
tiated features and generally border the dermis. These proliferative
cells act as the progenitors of postmitotic cell types, which undergo
terminal differentiation and form each structure's functional
components (e.g., the stratum corneum and hair). Though distinct
from each other, the epidermal and follicular differentiation
programs lead to comparable cellular changes, such as the
acquisition of a ¯attened shape, the accumulation of keratins, and
the breakdown of the nucleus. To produce a differentiated cell,
these programs proceed through an ordered series of events,
implying stepwise or temporal regulation of the process. While
many factors are known to in¯uence the formation of cutaneous
epithelia, much remains unknown about the commitment of a
progenitor cell to terminal differentiation, and the subsequent
stepwise control of the differentiation program.
Nude mice and rats are characterized by the abnormal devel-
opment of the epidermis, the lack of visible hair, and the absence of
a thymus (Flanagan, 1966; Pantelouris, 1973; KoÈpf-Maier et al,
1990). This phenotype results from inactivating mutations in a
single gene, originally designated whn (winged-helix nude) or hfh11
(hepatocyte nuclear factor 3/forkhead homolog 11) (Nehls et al,
1994, 1996; Segre et al, 1995), and recently renamed foxn1
(forkhead box n1) (Kaestner et al, 2000). The human and murine
Whn proteins are 85% identical (Schorpp et al, 1997), and a non-
sense mutation in human whn is associated with congenital alopecia
and severe T cell de®ciency (Frank et al, 1999). Thus, loss of Whn
activity in humans results in a disease that closely resembles the
nude phenotype, demonstrating the conservation of Whn function.
Whn is a member of the winged-helix or forkhead family of
transcription factors, which share a highly conserved stretch of 100
amino acids (Kaufmann and Knochel, 1996). This conserved region
forms a modi®ed helix±turn±helix domain that mediates DNA
binding (Kaufmann and Knochel, 1996). The negatively charged
C-terminal domain of Whn can stimulate transcription when fused
to the Gal4 DNA binding domain (Brissette et al, 1996;
SchuÈddekopf et al, 1996; Schlake et al, 1997), indicating that
Whn functions as a transcriptional activator.
In murine epidermis and hair follicles, nude mutations impair
terminal differentiation, as several differentiated structures (such as
the stratum corneum, inner root sheath, hair cortex, and hair
cuticle) fail to form properly (KoÈpf-Maier et al, 1990). During skin
development, epithelial cells induce whn expression as the ®rst signs
of terminal differentiation appear (Lee et al, 1999). In mature skin,
whn expression is maintained at sites displaying the early stages of
terminal differentiation, such as the ®rst suprabasal layer of the
epidermis and the supramatrical region of the hair bulb. Though
mainly restricted to postmitotic cells, whn expression is also
detected within progenitor cell compartments, marking a subset
of epithelial cells in the basal epidermal layer, outer root sheath, and
hair matrix. Based on the distribution of Ki-67, a nuclear marker of
proliferation, a small number of multiplying cells express whn (Lee
et al, 1999). Thus, whn expression seems to encompass the transition
from proliferation to differentiation, and whn activation may be one
of the ®rst steps in the terminal differentiation pathway. Consistent
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with its epithelial speci®city in the skin, whn expression is also
detected in the epithelial cells of several other organs, such as the
thymus, nail, tongue, palate, nasal cavity, and teeth (Lee et al, 1999).
In addition, whn homologs were identi®ed in species that do not
possess hair follicles or a thymus, such as amphioxus (Schlake et al,
1997) and fruit ¯ies (Strodicke et al, 2000; Sugimura et al, 2000).
Given whn's phylogenetic distribution as well as its murine
expression pattern, whn may control a common or fundamental
property of epithelia (Lee et al, 1999).
In previous studies, transgenic mice were generated in which
whn was placed under the control of the involucrin (inv) promoter
(Prowse et al, 1999). Involucrin, a component of the corni®ed
envelope (Rice and Green, 1979), is present in many strati®ed
epithelia and serves as a marker of terminal differentiation in the
epidermis and hair follicles (Rice and Green, 1979; Walts et al,
1985; de Viragh et al, 1994). Consistent with the inv expression
pattern, the inv±whn mice develop severe, often lethal, abnormal-
ities in the skin and urinary tract. These abnormalities include ¯aky,
shiny skin, misshapen, truncated hair shafts, and a loss of epidermal
barrier function, all of which indicate defects in differentiation.
Thus, whn overexpression, like the loss of whn function, disrupts the
terminal differentiation of the epidermis and hair follicles.
In this study, we examined Whn's role in differentiation using
murine keratinocyte cultures. Similar to its cutaneous expression
pattern, endogenous Whn is induced as primary keratinocytes
initiate terminal differentiation. In inv±whn cultures, whn over-
expression stimulates an early differentiation marker and suppresses
later markers, implicating Whn in the stepwise or temporal control
of the differentiation program. Furthermore, the mitogen-activated
protein kinase (MAPK) cascade functions as an upstream regulator
of Whn, as this pathway suppresses Whn levels in proliferating
keratinocytes and becomes inactivated with the onset of differen-
tiation. Thus, this study identi®es an early sequence of events in the
conversion of progenitor keratinocytes to a differentiated pheno-
type, as the inactivation of MAPK leads to the induction of Whn,
which in turn stimulates initial features of differentiation.
MATERIALS AND METHODS
Cells For analyses of whn expression and function, primary
keratinocytes were prepared from newborn inv±whn mice and their wild-
type littermates. Pups were genotyped by polymerase chain reaction of
tail DNA with primers corresponding to nucleotides 774±796 and 1449±
1470 of the mouse whn cDNA (Nehls et al, 1994). Keratinocytes were
grown in minimal essential medium containing a low calcium
concentration (0.05 mM), 4% chelex-treated fetal bovine serum, and
10 ng epidermal growth factor per ml as described previously (Hennings
et al, 1980). Terminal differentiation was induced by the addition of
CaCl2 (®nal concentration 2 mM). To block MAPK signaling, cells were
treated with the MEK inhibitors U0126 (Promega, Madison, WI; ®nal
concentration 1 mM) or PD098059 (LC Laboratories, Woburn, MA;
®nal concentration 50 mM).
Immunoprecipitations, immunoblotting, and antibodies For
analysis of Whn protein, cells were lyzed in buffer containing 50 mM
Tris, pH 8.0, 150 mM NaCl, 1% nonidet P40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 2 mM
phenylmethylsulfonyl ¯uoride, and 1 mM Na3VO4 (lysis buffer).
Immune complexes were recovered with protein G-sepharose. Sepharose
beads were washed twice in lysis buffer, once in buffer containing
100 mM Tris, pH 7.4, 500 mM NaCl, and twice in buffer containing
10 mM 1,4-piperazine-diethanesulfonic acid (PIPES), pH 7.0, 100 mM
NaCl.
For analysis of differentiation markers, cells were lyzed in buffer
containing 100 mM Tris, pH 6.8, 4% SDS, 20% glycerol, and 0.2%
bromophenol blue. Protein levels were normalized using Bradford assays
(Bio-Rad Laboratories, Hercules, CA). Proteins were electrophoresed on
SDS±polyacrylamide gels and transferred to Immobilon membranes
(Millipore, Bedford, MA). Following incubation with primary antibodies,
proteins were visualized using horseradish peroxidase-conjugated second-
ary antibodies (1:2000; Amersham Pharmacia Biotech, Piscataway, NJ)
and the enhanced chemiluminescence (ECL) detection system (NEN,
Boston, MA).
For analysis of MAPK phosphorylation, cells were lyzed in buffer
containing 50 mM Tris, pH 7.5, 1 mM ethylenediamine tetraacetic acid,
1 mM ethyleneglycol-bis-(b-aminoethylether)-N,N,N¢,N¢-tetraacetic
acid, 0.5 mM Na3VO4, 0.1% b-mercaptoethanol, 1% Triton X-100,
50 mM NaF, and 2 mM phenylmethylsulfonyl ¯uoride (MAPK assay
buffer A). Protein levels were normalized and immunoblots performed as
described above.
Polyclonal antibodies were raised against the full-length murine Whn
protein fused to glutathione S-transferase. To generate the fusion protein,
the whn cDNA (nucleotides 97±2038) was subcloned into the pGex2T
vector (Promega), and the construct was expressed in bacteria. The Whn
antibodies were af®nity puri®ed at Strategic Biosolutions Inc. (Ramona,
CA) and used at 1:500 dilution for immunoblots. Antibodies against
keratin 1 (K1; 1:1000), keratin 5 (K5; 1:1000), loricrin (1:1000), and
®laggrin (1:1000) were kindly provided by Dr G.P. Dotto (Massachusetts
General Hospital, Charlestown, MA). Involucrin antibodies (1:1000)
were from Covance (Richmond, CA), antibodies to phosphotyrosine
(0.1 mg per ml), phosphoserine (0.5 mg per ml), and phosphothreonine
(0.5 mg per ml) were from Zymed (South San Francisco, CA), and
monoclonal antibodies against Flag (M2; 10 mg per ml) were from Sigma
(St Louis, MO). Polyclonal antibodies that recognize total p42/p44
MAPK (phosphorylation-independent antibodies) were used at 1:500 for
immunoblots and 4 mg per immunoprecipitation (Upstate Biotechnology,
Lake Placid, NY). Antibodies speci®c for the phosphorylated forms of
the p42/p44 MAPK (0.1 mg per ml) were from Cell Signaling
Technology (Beverly, MA).
MAP kinase assay For analysis of MAP kinase activity, cells were
lyzed in MAPK assay buffer A. Protein levels were normalized using a
Bradford assay (Bio-Rad Laboratories), and MAPK was
immunoprecipitated from 1 mg total protein using 4 mg antibody to total
p42/p44 MAPK (Upstate Biotechnology). Immune complexes were
recovered with protein G sepharose beads, washed twice in MAPK Assay
Buffer A, and washed once with Assay Dilution Buffer [ADB; 20 mM
3-[N-morpholino]propanesulfonic acid (MOPS), pH 7.2, 25 mM
b-glycerophosphate, 5 mM ethyleneglycol-bis-(b-aminoethylether)-
N,N,N¢,N¢-tetraacetic acid, 1 mM Na3VO4, and 1 mM dithiothreitol].
Assays were carried out in 50 ml ADB containing 4 mM protein kinase C
inhibitor peptide, 0.4 mM protein kinase A inhibitor peptide, 4 mM
R24571, 15 mM MgCl2, 100 mM adenosine triphosphate, 0.4 mg myelin
basic protein (all from Upstate Biotechnology), and 10 mCi
[g-32P]adenosine triphosphate (3000 Ci per mM, NEN). Reactions were
incubated at 30°C with shaking for 20 min, brie¯y centrifuged, and
spotted (30 ml) in the center of a 2 cm 3 2 cm square of P81 paper
(Upstate Biotechnology). Assay squares were washed three times in
0.75% phosphoric acid, once in acetone, and scintillation counted.
Northern blot analysis Total RNA was isolated from keratinocytes
using RNeasy mini spin columns (Qiagen, Valencia, CA). Thirty
micrograms of total RNA was separated on 1.2% agarose/formaldehyde
gels and transferred to Hybond N membranes (Amersham Pharmacia
Biotech). Blots were hybridized with a 32P-labeled whn probe
corresponding to nucleotides 97±2038 of the mouse cDNA sequence. A
32P-labeled GAPDH probe (a 1.3 kb hybridized PstI fragment; Tso et al,
1985) was used as a loading control.
3H-thymidine labeling Cells were incubated with 0.5 mCi 3H-
thymidine (speci®c activity 5.0 Ci per mmol; Amersham Pharmacia
Biotech) for 3 h in 24-well plates. After washing twice with phosphate-
buffered saline, proteins were precipitated with 10% trichloroacetic acid
and resolubilized in 0.2 M NaOH. Incorporation of 3H-thymidine was
quantitated by scintillation counting.
Phosphatase assay Following immunoprecipitation as described
above, Whn protein bound to protein G-sepharose beads was washed in
buffer containing 50 mM Tris, pH 8.0, 10 mM MgCl2, 150 mM NaCl,
0.1% Triton X-100, 0.05% SDS, and 2 mM phenylmethylsulfonyl
¯uoride. Phosphatase reactions were incubated at 37°C for 4 h in buffer
containing 50 mM Tris, pH 8.0, 10 mM MgCl2, 150 mM NaCl, and
25 units of calf intestinal alkaline phosphatase (CIAP; Gibco BRL,
Gaithersburg, MD). To demonstrate speci®city, reactions were
performed in the presence or absence of 20 mM Na3VO4.
Phosphoamino acid analysis Keratinocytes were metabolically
labeled with carrier-free H3
32PO4 (1 mCi per ml; Amersham Pharmacia
Biotech) in phosphate-free Dulbecco's minimal Eagle's medium (Gibco
BRL) containing 1.8 mM CaCl2 for 2 h. Whn protein was then
immunoprecipitated as described above. Proteins were separated on 7.5%
SDS±polyacrylamide gels, transferred to Immobilon membranes, and
visualized by autoradiography. Membrane regions containing 32P-labeled
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Whn were excised, rehydrated in methanol, washed twice with water,
hydrolyzed with HCl (110°C, 2 h), and lyophilized (Kamps and Sefton,
1989). Individual 32P-labeled phosphoamino acids were resolved by two-
dimensional thin-layer electrophoresis as previously described (Cooper et
al, 1984).
RESULTS
Induction of Whn during terminal differentiation To
determine the whn expression pattern in vitro, primary
keratinocyte cultures were analyzed for Whn protein and RNA
levels. In medium containing low calcium concentrations (50 mM),
mouse keratinocytes exhibit many of the features of basal epidermal
cells, including continuous proliferation even after achieving
con¯uence (Hennings et al, 1980). While consisting mainly of
proliferative cells, low calcium cultures also generate more
differentiated cells that are ultimately shed into the medium
(Roop et al, 1987). Upon increasing the calcium content of the
medium to 2 mM (Hennings et al, 1980; Hennings and Holbrook,
1983), con¯uent cultures arrest growth and initiate a program of
terminal differentiation similar to that observed in the epidermis.
Whn protein levels were examined using polyclonal antibodies
raised against full-length murine Whn. Similar to other regulatory
proteins, the absolute amount of Whn is relatively low in wild-type
keratinocytes. Thus to measure Whn levels, the protein was
immunoprecipitated from concentrated cell extracts, and the
immunoprecipitations were then analyzed on immunoblots. Cell
extracts were prepared from wild-type keratinocytes under prolif-
erating (low calcium) and differentiating (2 mM calcium) condi-
tions. As shown in Fig 1(A) (left time course), Whn was weakly
detected in growing cultures and strongly induced during
keratinocyte differentiation. Whn levels increased rapidly following
the addition of calcium, peaking at 6 h, and then decreased by 24 h
after treatment. At all time points, Whn resolved into multiple,
closely migrating species, indicating post-translational modi®cation
of the protein. In an identical experiment using nude primary
keratinocytes, no Whn protein was detected, demonstrating the
speci®city of the antibodies (data not shown). As shown by
northern analyses, Whn transcript levels paralleled the protein
pro®le, although the transcript's changes were less dramatic
(Fig 1C). Thus, Whn mRNA and protein are induced during
the early stages of terminal differentiation in primary keratinocytes.
This expression pattern is essentially identical to that observed in
the epidermis, suggesting that whn is regulated by similar mech-
anisms in vitro and in vivo.
To investigate the effects of whn overexpression, Whn protein
levels were examined in primary keratinocytes derived from inv±
whn mice. In the epidermis, inv±whn expression is con®ned to
suprabasal (postmitotic) keratinocytes (Prowse et al, 1999), consist-
ent with the inv expression pattern (Rice and Green, 1979; Walts et
al, 1985; de Viragh et al, 1994). In wild-type keratinocyte cultures,
involucrin is induced by calcium treatment (Calautti et al, 1995) but
is also detected in a subset of attached cells under low calcium
conditions (Brissette et al, 1996), indicating the initiation of
differentiation. Like the analysis of endogenous whn expression,
Whn was immunoprecipitated from inv±whn cell extracts and
visualized on immunoblots. As shown in Fig 1(A, right time
course), Whn was easily detected under low calcium conditions and
strongly induced by calcium treatment. At each time point, the
protein resolved into multiple species, similar, if not identical, to
the Whn of wild-type keratinocytes. As transgenic cultures contain
relatively high amounts of Whn, the immunoprecipitations were
performed with only 2 mg of total protein extract. In contrast, the
detection of Whn in wild-type extracts required 8 mg of total
protein (Fig 1A, left time course). At all time points, inv±whn
cultures possessed higher levels of Whn than wild-type cultures. In
addition, the time course of whn expression differed between the
Figure 1. whn expression is modulated during differentiation in vitro. (A) Analysis of Whn protein. Cell lysates were prepared from wild-type
and inv±whn cultures before or after the addition of 2 mM calcium (as indicated). Whn was immunoprecipitated using 8 mg (wild-type) or 2 mg
(transgenic) of total protein. Immunoprecipitations were electrophoresed on 5% SDS±polyacrylamide gels and immunoblotted with antibodies against
Whn. (B) Relative levels of Flag-tagged and endogenous Whn. Transgenic keratinocytes were harvested under low or high calcium conditions as in
(A). In each lysate, the Flag-tagged Whn protein was depleted by two sequential immunoprecipitations with Flag M2 monoclonal antibodies (anti-Flag
IP). Remaining Whn protein was immunoprecipitated with polyclonal antibodies to Whn (anti-Whn IP). Following electrophoresis on 5% SDS±
polyacrylamide gels, the immunoprecipitated proteins were immunoblotted with Whn antibodies. In the anti-Flag time course, each time point
represents the combined yield of the two Flag immunoprecipitations. (C) Northern blot analysis of whn transcript. RNA was isolated from wild-type
keratinocytes before or after calcium treatment. Blots were hybridized with a 32P-labeled murine whn cDNA. To normalize the samples, blots were re-
probed with a 32P-labeled GAPDH fragment. (D) Whn phosphorylation. Cell lysates were prepared from transgenic keratinocytes after 6 h of calcium
treatment. Following immunoprecipitation, Whn was treated with phosphatase in the presence or absence of the phosphatase inhibitor sodium vanadate
(Na3VO4). Reactions were electrophoresed on 5% SDS±polyacrylamide gels and immunoblotted using antibodies to Whn. (E) Transgenic keratinocytes
were metabolically labeled with 32PO4 under high calcium conditions. Cell lysates were prepared after the indicated times of calcium treatment, and
immunoprecipitations were performed with Whn antibodies. The immunoprecipitated proteins were separated on 7.5% SDS±polyacrylamide gels,
transferred to Immobilon membranes, and visualized by autoradiography. (F) Phosphoamino acid analysis of Whn. 32P-labeled residues of Whn were
identi®ed by protein hydrolysis and two-dimensional thin-layer electrophoresis. Internal standards for phosphoserine (P-ser), phosphothreonine (P-thr)
and phosphotyrosine (P-tyr) are indicated. In wild-type keratinocytes, Whn protein and transcript increase during the early stages of terminal
differentiation (A, C). In transgenic cultures, Whn is present at substantial levels under low calcium conditions (A); following calcium treatment, the
protein exhibits a strong and prolonged induction, resulting in whn overexpression. The Flag-tagged Whn constitutes most of the Whn protein in inv±
whn cultures (B), demonstrating that the high Whn levels derive directly from the transgene. As shown by phosphatase treatment (D) and 32PO4
labeling (E), multiple species of Whn are generated by phosphorylation. This phosphorylation takes place primarily on serine residues (F).
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transgenic and wild-type keratinocytes. By 24 h after calcium
addition, Whn declined signi®cantly in wild-type cultures but
remained abundant in inv±whn cultures. Thus, high Whn levels
persisted longer in transgenic cultures, resulting in strong whn
expression during later stages of the differentiation program.
The Whn protein encoded by the transgene is tagged at the N-
terminus with a Flag epitope, enabling the exogenous protein to be
distinguished from endogenous Whn (Prowse et al, 1999). To
examine the relative amounts of tagged and endogenous Whn in
inv±whn cultures, transgenic cell lysates were depleted of the tagged
Whn by two consecutive immunoprecipitations with antibodies to
the Flag epitope. The remaining Whn in these lysates was then
immunoprecipitated with the Whn antibodies described above.
Figure 1(B) compares the Flag and Whn immunoprecipitations by
immunoblot analysis. As expected, the Flag immunoprecipitations
depleted most of the Whn from the lysates, leaving behind low
levels of the protein. Thus, transgene expression was directly
responsible for the observed increase in Whn.
As shown in Fig 1(A, B), Whn (both endogenous and tagged)
resolves as multiple bands during SDS±polyacrylamide gel electro-
phoresis, suggesting that the protein normally exists in several
forms. Since some, if not all, of these forms may result from post-
translational modi®cation, we determined whether Whn undergoes
phosphorylation. Whn was immunoprecipitated from either trans-
genic (Fig 1D) or wild-type (not shown) keratinocytes, and the
protein was incubated with phosphatase. On immunoblots,
phosphatase treatment converted the multiple Whn forms to a
single, faster-migrating species, strongly suggesting that the different
Whn forms are generated by phosphorylation. Inclusion of sodium
vanadate (Na3VO4), a phosphatase inhibitor, in the reaction
prevented the phosphatase from altering the mobility of the slower
migrating species. To con®rm Whn phosphorylation directly,
keratinocytes were labeled metabolically with 32P inorganic
phosphate (32PO4), and the phosphorylation status of Whn was
determined by immunoprecipitation and SDS±polyacrylamide gel
electrophoresis. As shown in Fig 1(E), Whn was labeled by the
32PO4, and the labeled protein displayed a banding pattern similar
to that observed on immunoblots. Moreover, the 32P-labeled Whn
generated several phosphorylated fragments when digested with
trypsin and resolved by two-dimensional chromatography (phos-
phopeptide mapping; data not shown). Thus, consistent with its
migration on immunoblots, the Whn protein is modi®ed by
phosphorylation at multiple sites. To identify the phosphorylated
residues, Whn was subjected to phosphoamino acid analysis, and as
shown in Fig 1(F), phosphorylation was predominantly on serine
residues. On immunoblots, Whn reacted with antibodies to the
phosphoryl forms of serine and threonine, indicating that the
protein may be phosphorylated on threonine residues as well (data
not shown). Thus, phosphorylation produces multiple species of
Whn, suggesting complex modulation of this protein's activity. In
all, this study represents one of the ®rst biochemical analyses of the
Whn protein.
Effects of Whn on terminal differentiation As keratinocytes
differentiate in the epidermis, the cells migrate towards the surface
and proceed through an ordered series of morphologic and
biochemical changes. Early terminal differentiation markers,
present in deeper layers of the epidermis, include keratins 1 and
10, whereas later markers, associated with the more super®cial
layers, include ®laggrin, loricrin, and involucrin (reviewed in
Fuchs, 1990). In culture, wild-type keratinocytes induce both early
and late markers in response to calcium (Hennings et al, 1980;
Hennings and Holbrook, 1983), thus exhibiting a differentiation
program similar to the epidermis. To assess Whn's role in terminal
differentiation, marker pro®les were compared in wild-type and
inv±whn primary cultures.
Under proliferating (low calcium) conditions, wild-type kerati-
nocytes displayed low levels of K1, and following calcium
treatment, this marker increased rapidly, persisting over a 24 h
time course (Fig 2A). In contrast, transgenic cultures possessed
abundant K1 both before and after the induction of differentiation
with calcium (Fig 2A). At all time points, K1 levels were higher in
inv±whn keratinocytes than in wild-type cells, and the upregulation
of this marker was particularly dramatic under low calcium
conditions. Thus, the overexpression of whn stimulated an increase
in K1, even under conditions that promote proliferation.
Filaggrin, the intermediate ®lament associated protein, is initially
synthesized as a high molecular weight precursor, pro®laggrin,
which contains many ®laggrin repeats (Resing et al, 1989). To
generate ®laggrin, pro®laggrin undergoes proteolytic processing
and consequently resolves as multiple bands by SDS±polyacryla-
mide gel electrophoresis. In both wild-type and transgenic
keratinocytes, pro®laggrin was detected at low levels under
proliferating conditions and induced in response to calcium
(Fig 2A). Nonetheless, a signi®cant difference emerged in
pro®laggrin levels during differentiation. Compared with wild-
type cells, the transgenic keratinocytes displayed a substantial
reduction in pro®laggrin following calcium treatment. Thus, in
contrast to its effect on K1, the inv±whn transgene caused a
downregulation of pro®laggrin in differentiating cells.
During differentiation in vitro, wild-type keratinocytes induce
involucrin and loricrin (both components of the corni®ed envel-
ope), but the levels of these proteins are signi®cantly higher in
detached cells than in adherent differentiating populations (Roop et
al, 1987). Thus to examine these markers, detached keratinocytes
were harvested from con¯uent wild-type or inv±whn cultures. As
shown in Fig 2B, transgenic keratinocytes exhibited a dramatic
decrease in involucrin and loricrin levels. At the same time, K1 was
elevated in detached inv±whn cells, consistent with the transgene's
effect on adherent differentiating keratinocytes. K5, a marker of the
basal epidermal layer, is not modulated in this culture system
Figure 2. Overexpression of whn alters the terminal
differentiation program. (A) Wild-type and inv±whn keratinocytes
were induced to differentiate by the addition of 2 mM calcium for the
indicated times. Total cell extracts were normalized for protein content,
electrophoresed on 7.5% SDS±polyacrylamide gels, and immunoblotted
with antibodies to pro®laggrin, K1, or K5. Compared with wild-type
cells, transgenic keratinocytes exhibit a stimulation of K1 and an
inhibition of pro®laggrin. K1 stimulation is observed in both growing
and differentiating cultures. (B) Detached cell populations were collected
from con¯uent wild-type and transgenic cultures maintained in low
calcium medium. The cells were harvested under low calcium conditions
as high calcium prevents keratinocyte detachment. Collected cells were
pelleted by centrifugation and then processed as in (A). Immunoblots
were probed with antibodies speci®c for involucrin, loricrin, K1, or K5.
In their detached populations, transgenic cultures possess lower levels of
loricrin and involucrin than wild-type cultures. Similar to the attached
inv±whn cells (A), the detached transgenic keratinocytes also display a
stimulation of K1.
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(Calautti et al, 1995) and served as a loading control in Fig 2(A, B).
Thus, like its effect on pro®laggrin, whn overexpression led to a
downregulation of the involucrin and loricrin proteins.
In all, whn overexpression resulted in higher levels of an early
differentiation marker (K1) and decreased levels of three later
markers (pro®laggrin, loricrin, and involucrin). These marker
pro®les indicate that Whn promotes the early stages of differen-
tiation while inhibiting the later stages.
Effects of the MAP kinase cascade on Whn and terminal
differentiation As shown in vivo (Lee et al, 1999) and in vitro
(Fig 1), Whn is induced as epithelial cells make the transition from
proliferation to differentiation. Though little is known about the
control of keratinocyte fate, the decision to divide or differentiate
may be in¯uenced by the p42 and p44 MAPKs. In many cell types,
the p42/p44 MAPKs transduce mitogenic signals to substrates such
as transcription factors and other kinases (reviewed in Seger and
Krebs, 1995; Chang and Karin, 2001). The signals are received
from MAP kinase kinases (MEK), which phosphorylate and
thereby activate the MAPKs. In human keratinocyte cultures,
epidermal growth factor stimulates the activity of p42 MAPK,
and this response is blocked by calcium treatment (Medema et al,
1994). Moreover, following the introduction of a dominant-
negative MEK1, human keratinocytes exhibit reductions in clonal
growth and colony-forming ef®ciency (Zhu et al, 1999). These
effects correlate with the inhibition of p42/p44 MAPK
activity, suggesting that keratinocytes require MAPK signaling to
maintain their proliferative potential (Zhu et al, 1999). Thus, we
investigated whether the p42/p44 MAPK cascade in¯uences whn
expression.
Wild-type keratinocytes were treated with U0126 (Favata et al,
1998) or PD098059 (Alessi et al, 1995), which are speci®c
inhibitors of MEK1 and block the activation of its substrates, the
p42/p44 MAPKs. Under low calcium conditions, both inhibitors
stimulated a great increase in Whn, and these Whn levels were
higher than the level observed after calcium treatment (Fig 3A).
Thus, the MEK1 inhibitors are the strongest inducers of Whn
found to date. As Whn was stimulated by two different inhibitors, it
is likely that MEK1 mediates this effect, and that MAPK signaling
suppresses Whn levels in proliferating keratinocytes. These results
provide the ®rst insight into Whn regulation at the molecular level.
To date, there has been little study of how the MAP kinases
affect or respond to keratinocyte decisions. For example, it is not
known whether MAPK activity changes as keratinocytes lose
proliferative potential or initiate terminal differentiation. Thus to
correlate MAPK function with keratinocyte behavior, p42/p44
MAPK status was examined using antibodies speci®c for their
phosphorylated forms. As shown in Fig 3B (upper panel), the p42/
p44 MAPKs were phosphorylated under low calcium conditions,
indicating that these kinases are active in proliferating keratinocytes.
Following calcium addition, the phosphorylated forms of both
proteins rapidly decreased and remained low as cells progressed
through the differentiation program. This decrease resulted strictly
from a change in phosphorylation status, as the total level of MAPK
protein was not affected by calcium treatment (Fig 3B, lower
panel). To examine MAPK activity directly, total p42/p44 MAPK
was immunoprecipitated and assayed for the ability to phosphor-
ylate myelin basic protein. Consistent with the phosphorylation
pattern, p42/p44 MAPK activity declined rapidly following the
addition of calcium (Fig 3C). Thus, these MAPKs become
inactivated as keratinocytes commit to the terminal differentiation
program.
Figure 3. whn expression is modulated by inhibitors of MEK1.
(A) Analysis of Whn protein. Wild-type keratinocytes were treated for
6 h with 2 mM calcium, 1 mM U0126, or 50 mM PD098059. Cell
lysates were prepared from treated or untreated cultures, and Whn levels
were analyzed by immunoprecipitation/immunoblot as in Fig 1(A). (B)
MAP kinase phosphorylation status in primary keratinocytes. Cell lysates
were prepared from wild-type cultures at the indicated times after
calcium addition (2 mM). Total soluble protein (200 mg) was
electrophoresed on 10% SDS±polyacrylamide gels and immunoblotted
using antibodies speci®c for phosphorylated p42/p44 MAPK. To
normalize samples, membranes were reprobed with antibodies that
recognize total p42/p44 MAPK (lower panel). (C) MAP kinase activity in
primary keratinocytes. Wild-type cultures were treated with 2 mM
calcium for the indicated times. p42/p44 MAP kinase was
immunoprecipitated from 1 mg total soluble protein and assayed for
activity as described in Materials and Methods. The graph expresses the
phosphorylation of myelin basic protein as a percentage of the activity
found under low calcium conditions, with standard deviation indicated.
Figure 4. Inhibition of MEK1 causes early features of terminal
differentiation. (A) Wild-type keratinocytes were treated with 2 mM
calcium or 1 mM U0126 for 6 h. Total cell protein (50 mg) was
electrophoresed on 7.5% SDS±polyacrylamide gels and immunoblotted
with antibodies to K1, pro®laggrin, or K5. (B) Wild-type keratinocytes
were labeled with 3H-thymidine following 24 h of calcium (2 mM) or
U0126 (1 mM) treatment. The graph expresses 3H-thymidine
incorporation as a percentage, where 100% equals the labeling of
untreated cultures.
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As shown in Fig 2, inv±whn keratinocytes display an altered
differentiation program, as early differentiation markers increase
and later markers decrease. Since MEK1 inhibitors induce high
levels of Whn (analogous to the inv±whn transgene), wild-type
keratinocytes were examined for their marker pro®le following
U0126 treatment. Under low calcium conditions, the MEK1
inhibitor stimulated an increase in K1 (Fig 4A), and this early
marker, like Whn (Fig 3A), was higher in the presence of U0126
than calcium. Despite this apparent start of differentiation, the
U0126-treated cells failed to induce the later marker pro®laggrin
(Fig 4A), instead displaying a small decrease in this protein. In
conjunction with this marker pro®le, U0126 (like calcium) caused a
substantial reduction in the incorporation of 3H-thymidine
(Fig 4B), showing the arrest of cell division, another early event
in the differentiation program. Thus, the inhibition of the MAPK
pathway activates early, but not later, features of terminal
differentiation, effects essentially identical to the overexpression
of whn.
DISCUSSION
During the self-renewal of the epidermis and hair follicles,
postmitotic, differentiating cells arise from less differentiated
populations capable of proliferation. In this study, we identify a
role for Whn in the conversion of progenitor cells to a
differentiated phenotype.
In murine epidermis and hair follicles, the induction of whn
expression correlates with the initiation of terminal differentiation
(Lee et al, 1999). During epidermal development, whn is induced at
the same time that K1 ®rst appears (embryonic stage E15.5), and
whn expression is detected principally in suprabasal cells. As the
epidermis matures, whn is expressed primarily in the ®rst suprabasal
layer, which contains cells in the early stages of terminal
differentiation. As epidermal keratinocytes migrate to more super-
®cial layers, whn expression disappears, and thus keratinocytes
suppress whn during later stages of differentiation (Lee et al, 1999;
Prowse et al, 1999).
As shown here, primary keratinocytes also induce whn expression
during the early stages of terminal differentiation. Under conditions
that stimulate proliferation, wild-type cultures possess low levels of
Whn, and following calcium treatment, Whn increases dramatic-
ally, peaking within 6 h. As cells proceed through the differenti-
ation program, the protein declines, analogous to the whn
expression pattern in the epidermis. In parallel with the protein,
the Whn transcript also rises and falls, but the changes in Whn
mRNA appear smaller than the changes in Whn protein.
Consistent with the increase in Whn transcript, the Whn promoter
(Schorpp et al, 1997) contains potential binding sites for AP-1, a
transcription factor that activates many genes associated with
keratinocyte differentiation (Eckert et al, 1997). In all, the results
suggest regulation of Whn at several levels. As shown in skin, whn
expression is controlled, at least in part, at the level of transcription,
since Whn promoter activity is induced as cells initiate terminal
differentiation (Lee et al, 1999). In culture, whn may undergo
similar transcriptional regulation, since the Whn transcript increases
in differentiating cells. Despite this increase, Whn mRNA levels do
not correspond precisely to Whn protein levels, as the protein
exhibits greater changes than the transcript. Thus, in addition to
transcriptional controls, the results suggest the regulation of Whn at
the level of translation or protein stability.
In nude epidermis and hair follicles, the differentiating cells
exhibit morphologic defects, and some differentiated structures
(e.g., the hair cortex and cuticle) often fail to form entirely (KoÈpf-
Maier et al, 1990). Consistent with this impaired differentiation,
nude skin contains reduced transcript levels of several hair keratin
genes (Schlake et al, 2000; Schorpp et al, 2000). In culture, nude
keratinocytes display an abnormal differentiation program, as early
markers decrease and later markers increase (Brissette et al, 1996).
Given these phenotypic effects, we proposed that Whn directly
regulates genes associated with terminal differentiation (Lee et al,
1999; Prowse et al, 1999). Nonetheless, it remained possible that
Whn's effects were indirect and that the nude differentiation defects
were a secondary consequence of other perturbations. As shown in
this study, whn overexpression shifts the balance of markers in the
differentiation program, suggesting a direct role for Whn in the
regulation of differentiation. In inv±whn keratinocytes, high Whn
levels induce the early marker K1, even under conditions that
stimulate proliferation. Concomitantly, the exogenous Whn
inhibits pro®laggrin, loricrin, and involucrin, three later markers
of differentiation. This marker pro®le is consistent with the
epidermal whn expression pattern, as Whn is induced during early
differentiation stages and repressed during later stages (Lee et al,
1999; Prowse et al, 1999). Taking these ®ndings together, it is likely
that Whn promotes early features of differentiation, directly
activating part of the differentiation program. At the same time,
Whn appears to suppress or inhibit the later features of differen-
tiating cells. Thus, the results support a role for Whn in the stepwise
or temporal regulation of terminal differentiation. That is, Whn can
in¯uence a cell's progress through the differentiation program and
ensure that events are carried out in the proper sequence.
While we do not know the mechanism by which Whn inhibits
later differentiation markers, we note that Whn reduces endogen-
ous involucrin levels without clearly affecting transgene expression,
which is driven by the involucrin promoter. The transgene's
promoter is carried within a 3.7 kb genomic fragment (Carroll et al,
1993), and it is possible that this fragment lacks promoter elements
mediating Whn repression. Alternatively, Whn may suppress
endogenous involucrin levels through post-transcriptional regula-
tion.
In addition to its induction during terminal differentiation, Whn
is phosphorylated at multiple sites, and the phosphorylated residues
consist primarily of serine. Whn belongs to the winged-helix/
forkhead family of transcription factors (Kaestner et al, 2000), and in
studies of other family members, phosphorylation modulated
transcriptional activity or nuclear translocation (Biggs et al, 1999;
Brunet et al, 1999; Kops et al, 1999). As shown by immunoblots,
phosphorylation generates multiple species of Whn, which raises
the possibility that different species perform different functions.
The differentiation of a cutaneous epithelial cell can be divided
into two distinct components: the loss of the ability to multiply and
the acquisition of specialized characteristics. In this study, we
present evidence that whn expression is regulated by a cell's ability
to multiply. Whn is strongly induced by two different inhibitors of
MEK1, which block activation of the p42/p44 MAPKs. The p42/
p44 MAPK pathway is activated through Ras signaling and known
to in¯uence cell proliferation as well as other responses to
extracellular factors (Chang and Karin, 2001). In human keratino-
cytes, growth potential decreases following the inhibition of
MAPK activity, suggesting a role for MAPK signaling in the
maintenance of progenitor populations (Zhu et al, 1999). As an
extension of this work, we show that the MEK1 inhibitor U0126
arrests the proliferation of murine keratinocytes. Moreover, we
demonstrate that MAPK signaling changes dramatically as kerati-
nocytes initiate differentiation. Following calcium treatment,
keratinocytes rapidly inactivate the p42 and p44 MAPKs, which
implicates these kinases in the switch from a proliferative to a
postmitotic state. Taking the results together, the p42/p44 MAPKs
perform the related functions of promoting keratinocyte prolifer-
ation and suppressing Whn levels. As cells commit to the
differentiation program, the MAPK pathway is inactivated, and
Whn is induced. This increase in Whn then stimulates the
acquisition of specialized characteristics. Thus, MAPK inactivation
and Whn induction are part of an early series of steps that convert
progenitor cells to a differentiated phenotype.
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